Please ensure Javascript is enabled for purposes of website accessibility
Accessibility Menu
Co-Diagnostics Stock Quote

Co-Diagnostics (NASDAQ: CODX)

$1.16
(2.7%)
$0.03
Price as of March 1, 2024, 4:00 p.m. ET

You’re reading a free stock page from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Co-Diagnostics Return vs. S&P

1 Year 5 Year 5 Year Annualized Since IPO
CODX -61.20% -3.33% -0.68% -80%
S&P +29.03% +83.23% +12.86% +110%

Co-Diagnostics Company Info

Co-Diagnostics, Inc. engages in the development and innovation of molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications. Its diagnostics systems enable very rapid, low-cost, molecular testing for organisms and genetic diseases by automating historically complex procedures in both the development and administration of tests. The company was founded by Brent C. Satterfield and Dwight Howard Egan on April 18, 2013 and is headquartered in Salt Lake City, UT.

News & Analysis

The Fool has written over 100 articles on Co-Diagnostics.

Valuation

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.